FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort

BACKGROUND: The role of second-line therapy in gastric cancer patients mostly stemmed from clinical trials with monochemotherapy carried out in Asian countries. Nevertheless, these results cannot be broadly generalized as molecular studies suggested the existence of different sets of deregulated gen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Maugeri-Saccà, Marcello, Pizzuti, Laura, Sergi, Domenico, Barba, Maddalena, Belli, Franca, Fattoruso, Silvia Ileana, Giannarelli, Diana, Amodio, Antonella, Boggia, Sara, Vici, Patrizia, Di Lauro, Luigi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3850248/
https://ncbi.nlm.nih.gov/pubmed/24330513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-32-67
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados